Your browser doesn't support javascript.
loading
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Arboleda-Velasquez, Joseph F; Lopera, Francisco; O'Hare, Michael; Delgado-Tirado, Santiago; Marino, Claudia; Chmielewska, Natalia; Saez-Torres, Kahira L; Amarnani, Dhanesh; Schultz, Aaron P; Sperling, Reisa A; Leyton-Cifuentes, David; Chen, Kewei; Baena, Ana; Aguillon, David; Rios-Romenets, Silvia; Giraldo, Margarita; Guzmán-Vélez, Edmarie; Norton, Daniel J; Pardilla-Delgado, Enmanuelle; Artola, Arabiye; Sanchez, Justin S; Acosta-Uribe, Juliana; Lalli, Matthew; Kosik, Kenneth S; Huentelman, Matthew J; Zetterberg, Henrik; Blennow, Kaj; Reiman, Rebecca A; Luo, Ji; Chen, Yinghua; Thiyyagura, Pradeep; Su, Yi; Jun, Gyungah R; Naymik, Marcus; Gai, Xiaowu; Bootwalla, Moiz; Ji, Jianling; Shen, Lishuang; Miller, John B; Kim, Leo A; Tariot, Pierre N; Johnson, Keith A; Reiman, Eric M; Quiroz, Yakeel T.
Afiliação
  • Arboleda-Velasquez JF; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. joseph_arboleda@meei.harvard.edu.
  • Lopera F; Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
  • O'Hare M; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Delgado-Tirado S; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Marino C; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Chmielewska N; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Saez-Torres KL; Boston College, Boston, MA, USA.
  • Amarnani D; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Schultz AP; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Sperling RA; Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA.
  • Leyton-Cifuentes D; Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA.
  • Chen K; Brigham and Women's Hospital and the Department of Neurology, Harvard Medical School, Boston, MA, USA.
  • Baena A; Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
  • Aguillon D; Universidad Escuela de Ingenieria de Antioquia-EIA, Medellin, Colombia.
  • Rios-Romenets S; The Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Giraldo M; University of Arizona, Tucson, AZ, USA.
  • Guzmán-Vélez E; Arizona State University, Tempe, AZ, USA.
  • Norton DJ; Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
  • Pardilla-Delgado E; Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
  • Artola A; Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
  • Sanchez JS; Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
  • Acosta-Uribe J; Massachusetts General Hospital and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Lalli M; Massachusetts General Hospital and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Kosik KS; Department of Psychology, Gordon College, Wenham, MA, USA.
  • Huentelman MJ; Massachusetts General Hospital and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Zetterberg H; Massachusetts General Hospital and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Blennow K; Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA.
  • Reiman RA; Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
  • Luo J; Neuroscience Research Institute, Department of Molecular Cellular Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA, USA.
  • Chen Y; Neuroscience Research Institute, Department of Molecular Cellular Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA, USA.
  • Thiyyagura P; Neuroscience Research Institute, Department of Molecular Cellular Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA, USA.
  • Su Y; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Jun GR; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Naymik M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Gai X; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
  • Bootwalla M; UK Dementia Research Institute at UCL, London, UK.
  • Ji J; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Shen L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
  • Miller JB; Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.
  • Kim LA; The Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Tariot PN; The Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Johnson KA; The Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Reiman EM; The Banner Alzheimer's Institute, Phoenix, AZ, USA.
  • Quiroz YT; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Nat Med ; 25(11): 1680-1683, 2019 11.
Article em En | MEDLINE | ID: mdl-31686034
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Apolipoproteína E3 / Presenilina-1 / Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Apolipoproteína E3 / Presenilina-1 / Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos